Mohamed Ibrahim Fahim
Mohamed Ibrahim Fahim has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Rasha Mahmoud Allam
Cancer Epidemiology and Biostatistics, National Cancer Institute, Cairo University, Cairo 11796, Egypt
3 shared publications - Abdelmaksoud Mohamed Ali
Surgical Oncology Department, National Cancer Institute-Cairo University, 1 Kasr El- Aini Street, Foum El- Khalig, Cairo, 11796 Egypt
2 shared publications - Amr Kamal
Surgical Oncology Department, National Cancer Institute, Cairo University, 11796 Cairo, Egypt
2 shared publications - Mamdouh Mohamed Mounir
Surgical Oncology Department, National Cancer Institute-Cairo University, Cairo, Egypt
2 shared publications - Ahmed Mostafa Ahmed Mahmoud
Surgical Oncology Department, National Cancer Institute, Cairo University, Egypt
1 shared publication - Assem Ahmed Elbrashy
Surgical Oncology Department, National Cancer Institute-Cairo University, Foum El-Khalig, Egypt
1 shared publication
Latest Publications
- 25 March 2024
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 14-17
The Potential Prognostic Impact of Associated Peritoneal Carcinomatosis in Patients with Stage II and III Epithelial Ovarian Cancer Who Had Upfront Complete Cytoreduction
Background The presence of metastatic peritoneal nodules in epithelial ovarian cancer (EOC) is considered a prognostic factor of both overall survival and disease-free survival. The goal of this study is to assess the potential prognostic effect of associated peritoneal carcinomatosis and PCI in stage II and III EOC patients after undergoing complete cytoreduction (CC score 0 or 1). Patients and Methods This is a retrospective cohort study including 50 high-grade serous EOC cases treated and followed up from 2012 and 2016. Twenty-three cases had peritoneal nodules at the time of exploration. PCI was assessed intraoperatively in each case. Twenty-seven cases had no peritoneal nodules (were given PCI 0). Results The presence of peritoneal nodules, presence of ascites, and stage of the disease had statistically significant impact on overall survival, but with multivariate analysis, only presence of peritoneal nodules was associated with a statistically significant reduced overall survival (HR 6.192; 95% CI 1.248–30.720; P value 0.026). The presence of peritoneal nodules was associated with a statistically significant higher incidence of postoperative death (P value 0.038). PCI had no statistically significant impact on overall survival, disease-free survival, or incidence of postoperative death (within 30 days after surgery). Conclusion The presence of peritoneal nodules had a statistically significant impact on overall survival and incidence of postoperative death. There was no statistically significant prognostic impact of PCI in stage II and III EOC patients who had complete cytoreduction.
- 25 March 2024
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 14-17
The Potential Prognostic Impact of Associated Peritoneal Carcinomatosis in Patients with Stage II and III Epithelial Ovarian Cancer Who Had Upfront Complete Cytoreduction
Background The presence of metastatic peritoneal nodules in epithelial ovarian cancer (EOC) is considered a prognostic factor of both overall survival and disease-free survival. The goal of this study is to assess the potential prognostic effect of associated peritoneal carcinomatosis and PCI in stage II and III EOC patients after undergoing complete cytoreduction (CC score 0 or 1). Patients and Methods This is a retrospective cohort study including 50 high-grade serous EOC cases treated and followed up from 2012 and 2016. Twenty-three cases had peritoneal nodules at the time of exploration. PCI was assessed intraoperatively in each case. Twenty-seven cases had no peritoneal nodules (were given PCI 0). Results The presence of peritoneal nodules, presence of ascites, and stage of the disease had statistically significant impact on overall survival, but with multivariate analysis, only presence of peritoneal nodules was associated with a statistically significant reduced overall survival (HR 6.192; 95% CI 1.248–30.720; P value 0.026). The presence of peritoneal nodules was associated with a statistically significant higher incidence of postoperative death (P value 0.038). PCI had no statistically significant impact on overall survival, disease-free survival, or incidence of postoperative death (within 30 days after surgery). Conclusion The presence of peritoneal nodules had a statistically significant impact on overall survival and incidence of postoperative death. There was no statistically significant prognostic impact of PCI in stage II and III EOC patients who had complete cytoreduction.
- 14 April 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 12 (2) , 450
Correction to: Role of Enhanced Recovery Program for Colorectal Cancer Patients: National Cancer Institute Experience
- 14 April 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 12 (2) , 450
Correction to: Role of Enhanced Recovery Program for Colorectal Cancer Patients: National Cancer Institute Experience
- 15 January 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 12 (1) , 218-221
Role of Enhanced Recovery Program for Colorectal Cancer Patients: National Cancer Institute Experience
Enhanced recovery program (ERP) was introduced in patients scheduled for colorectal surgical procedures to enhance gastrointestinal recovery and shorten their hospital stay. This study aims to evaluate the role of ERP in colorectal cancer patients. A prospective cohort study performed at National Cancer Institute—Cairo University including 50 patients with colorectal cancer treated between October 2016 and May 2017. They were divided in 2 equal groups: study group (ERP group) and control group (conventional protocol group). Incidence of postoperative morbidity was greater in the control group compared to the study group. Only the incidence of paralytic ileus was greater in the study group. The study group had a statistically significant hospital stay length compared to the control group. ERP was associated with lower incidence of postoperative morbidity excluding incidence of paralytic ileus; also, it was associated with a shorter hospital stay.
- 15 January 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 12 (1) , 218-221
Role of Enhanced Recovery Program for Colorectal Cancer Patients: National Cancer Institute Experience
Enhanced recovery program (ERP) was introduced in patients scheduled for colorectal surgical procedures to enhance gastrointestinal recovery and shorten their hospital stay. This study aims to evaluate the role of ERP in colorectal cancer patients. A prospective cohort study performed at National Cancer Institute—Cairo University including 50 patients with colorectal cancer treated between October 2016 and May 2017. They were divided in 2 equal groups: study group (ERP group) and control group (conventional protocol group). Incidence of postoperative morbidity was greater in the control group compared to the study group. Only the incidence of paralytic ileus was greater in the study group. The study group had a statistically significant hospital stay length compared to the control group. ERP was associated with lower incidence of postoperative morbidity excluding incidence of paralytic ileus; also, it was associated with a shorter hospital stay.
- 2 December 2019
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 11 (2) , 196-200
Impact of Lymph Node Sampling in Stage II and III Epithelial Ovarian Cancer Patients with Clinically Negative Lymph Nodes
The main surgical treatment of stage II and III epithelial ovarian cancer (EOC) is complete cytoreduction, while the main role of lymph node sampling is to exclude microscopic stage III disease in an apparent stage I EOC. This study aims to evaluate the impact of lymph node sampling in stage II and III EOC patients with clinically negative lymph nodes. This is a retrospective cohort study including 51 stage II and III EOC patients treated and followed up between 2012 and 2016. They were treated by complete cytoreduction. Sixteen cases had lymph node sampling, while it was not done in 35 cases. The study was performed at National Cancer Institute (NCI)-Cairo University. There was no statistically significant difference regarding overall survival (P value 0.649) or disease-free survival (P value 0.372) between the group of patients who had lymph node sampling and the other group of patients who had no lymph node sampling. Lymph node ratio (LNR) was not associated with a statistically significant impact regarding overall survival or disease-free survival. There is no impact of lymph node sampling on stage II and III EOC patients with clinically negative lymph nodes.
- 2 December 2019
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 11 (2) , 196-200
Impact of Lymph Node Sampling in Stage II and III Epithelial Ovarian Cancer Patients with Clinically Negative Lymph Nodes
The main surgical treatment of stage II and III epithelial ovarian cancer (EOC) is complete cytoreduction, while the main role of lymph node sampling is to exclude microscopic stage III disease in an apparent stage I EOC. This study aims to evaluate the impact of lymph node sampling in stage II and III EOC patients with clinically negative lymph nodes. This is a retrospective cohort study including 51 stage II and III EOC patients treated and followed up between 2012 and 2016. They were treated by complete cytoreduction. Sixteen cases had lymph node sampling, while it was not done in 35 cases. The study was performed at National Cancer Institute (NCI)-Cairo University. There was no statistically significant difference regarding overall survival (P value 0.649) or disease-free survival (P value 0.372) between the group of patients who had lymph node sampling and the other group of patients who had no lymph node sampling. Lymph node ratio (LNR) was not associated with a statistically significant impact regarding overall survival or disease-free survival. There is no impact of lymph node sampling on stage II and III EOC patients with clinically negative lymph nodes.
- 13 August 2019
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 10 (4) , 640-642
Methods of Treatment and Outcome for Ovarian Germ Cell Tumors
Ovarian germ cell tumors account for about 15–20% of all ovarian tumors. They occur mainly in girls, adolescents, and young adults. This study aims to assess the different clinico-pathological factors of ovarian germ cell tumors, treatment methods, and outcome. This is a retrospective observational cohort study including 54 cases with OGCTs which were studied from the period between January 2013 and December 2016. The study was performed at National Cancer Institute (NCI)–Cairo University, Egypt. All cases had cytoreductive surgery in the form of unilateral salpingo-oophorectomy in 42 cases and total abdominal hysterectomy in 12 cases. Complete cytoreduction was achieved in 46 cases while 8 cases had residual disease after surgery. Adjuvant chemotherapy was given in 26 cases (stage II, III, and IV malignant OGCTs). The main treatment of ovarian germ cell tumors is complete cytoreductive surgery which can be achieved in many cases with unilateral salpingo-oophorectomy. Adjuvant chemotherapy is highly recommended in case of malignant ovarian germ cell tumors.
- 13 August 2019
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 10 (4) , 640-642
Methods of Treatment and Outcome for Ovarian Germ Cell Tumors
Ovarian germ cell tumors account for about 15–20% of all ovarian tumors. They occur mainly in girls, adolescents, and young adults. This study aims to assess the different clinico-pathological factors of ovarian germ cell tumors, treatment methods, and outcome. This is a retrospective observational cohort study including 54 cases with OGCTs which were studied from the period between January 2013 and December 2016. The study was performed at National Cancer Institute (NCI)–Cairo University, Egypt. All cases had cytoreductive surgery in the form of unilateral salpingo-oophorectomy in 42 cases and total abdominal hysterectomy in 12 cases. Complete cytoreduction was achieved in 46 cases while 8 cases had residual disease after surgery. Adjuvant chemotherapy was given in 26 cases (stage II, III, and IV malignant OGCTs). The main treatment of ovarian germ cell tumors is complete cytoreductive surgery which can be achieved in many cases with unilateral salpingo-oophorectomy. Adjuvant chemotherapy is highly recommended in case of malignant ovarian germ cell tumors.
- 6 January 2019
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 10 (3) , 417-421
Hyperthermic Intraperitoneal Chemotherapy as a Treatment for Epithelial Ovarian Cancer
Treatment by cytoreductive surgery (CRS) and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) has been an option for selected patients with peritoneal carcinomatosis. This study aims to evaluate the impact of HIPEC in epithelial ovarian cancer (EOC). A retrospective observational cohort study including 48 EOC patients treated and followed up between 2012 and 2016. Thirty-seven cases were treated by CRS only, while 11 cases were treated by CRS and HIPEC. The study was performed at National Cancer Institute (NCI)—Cairo University. There was no statistically significant difference regarding overall survival or disease-free survival between the group of EOC patients treated by CRS only and the one treated by CRS and HIPEC. Presence of ascites and histological types (serous/non-serous) were the significant independent variables related to overall survival. Presence of ascites was the only independent variable associated with a significant relation to disease-free survival. No statistically significant impact of HIPEC in treatment of EOC was found in this study.
- 6 January 2019
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 10 (3) , 417-421
Hyperthermic Intraperitoneal Chemotherapy as a Treatment for Epithelial Ovarian Cancer
Treatment by cytoreductive surgery (CRS) and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) has been an option for selected patients with peritoneal carcinomatosis. This study aims to evaluate the impact of HIPEC in epithelial ovarian cancer (EOC). A retrospective observational cohort study including 48 EOC patients treated and followed up between 2012 and 2016. Thirty-seven cases were treated by CRS only, while 11 cases were treated by CRS and HIPEC. The study was performed at National Cancer Institute (NCI)—Cairo University. There was no statistically significant difference regarding overall survival or disease-free survival between the group of EOC patients treated by CRS only and the one treated by CRS and HIPEC. Presence of ascites and histological types (serous/non-serous) were the significant independent variables related to overall survival. Presence of ascites was the only independent variable associated with a significant relation to disease-free survival. No statistically significant impact of HIPEC in treatment of EOC was found in this study.